The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
Was this article valuable?
Here are more articles you may enjoy.
Bayer to Make $10.5 Billion Push to Settle Roundup Cases 
Asbestos Lawsuits Prompt Vanderbilt Minerals to File Bankruptcy 
AIG’s Zaffino: Outcomes From AI Use Went From ‘Aspirational’ to ‘Beyond Expectations’ 
UK Floods Raise Specter of ‘Mortgage Prisoners’ Across Banks 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.